Substance / Medication

Vancomycin hydrochloride

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Calcium alginate particles for the combined delivery of platelet lysate and vancomycin hydrochloride in chronic skin ulcers.
Mori Michela, Rossi Silvia, Bonferoni Maria Cristina et al. · Int J Pharm · 2014
PMID: 24368099Observational
Comparing the efficacy of three bioceramic matrices for the release of vancomycin hydrochloride.
Jiang Peih-Jeng, Patel Sarika, Gbureck Uwe et al. · J Biomed Mater Res B Appl Biomater · 2010
PMID: 20024966Observational
[Pharmaceutical investigation of vancomycin hydrochloride eye drops and their topical application to MRSA eye infection].
Itoh M, Aoyama T, Iemoto A et al. · Yakugaku Zasshi · 2001
PMID: 11433777Case Report
Effect of Thickening Agents on the In Vitro Antibacterial Activity of Vancomycin Hydrochloride Powder.
Omi Akiko, Doi Nobuyuki, Akiyama Shigeo et al. · Yakugaku Zasshi · 2023
PMID: 37517997Other
Influence of Choline-Based Ionogel on Transdermal Delivery of Vancomycin Hydrochloride.
Datta Deepanjan, Bandi Sony Priyanka, Venuganti Venkata Vamsi Krishna · Mol Pharm · 2025
PMID: 40377918PreclinicalFull text (PMC)

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Vancomycin hydrochloride (substance)
SNOMED CT
66509009
UMLS CUI
C0205992

Clinical Data

This intervention maps to 6 entities in the Healos knowledge graph.

6
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.